← Back to Screener
Alphatec Holdings, Inc. (ATEC)
Price$7.48
Value ScoreD
Growth ScoreB
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-76.41%
Price vs S&P 500 (4W)-30.67%
VGM Score43.77
Market Capitalization$1.22B
All Metrics
P/CF (Annual)26.96x
Book Value / Share (Quarterly)$0.12
P/TBV (Annual)63.76x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)29.62%
Cash Flow / Share (Quarterly)$-0.01
Price vs S&P 500 (YTD)-74.10%
Gross Margin (TTM)70.18%
Net Profit Margin (TTM)-15.93%
EPS (TTM)$-0.83
10-Day Avg Trading Volume2.60M
EPS Excl Extra (TTM)$-0.83
Revenue Growth (5Y)39.45%
EPS (Annual)$-0.96
ROI (Annual)-23.81%
Gross Margin (Annual)69.60%
Net Profit Margin (5Y Avg)-37.33%
Cash / Share (Quarterly)$0.91
Revenue Growth QoQ (YoY)13.55%
ROA (Last FY)-18.12%
Revenue Growth TTM (YoY)22.55%
EBITD / Share (TTM)$-0.30
ROE (5Y Avg)-498.29%
Operating Margin (TTM)-7.68%
Cash Flow / Share (Annual)$-0.03
P/B Ratio66.80x
P/B Ratio (Quarterly)90.20x
Net Income / Employee (Annual)$-157,000
EV / Revenue (TTM)2.10x
Net Interest Coverage (TTM)-2.17x
ROA (TTM)-15.83%
EV / EBITDA (TTM)196.79x
EPS Incl Extra (Annual)$-0.96
Current Ratio (Annual)2.06x
Quick Ratio (Quarterly)1.05x
3-Month Avg Trading Volume3.14M
52-Week Price Return-37.80%
Revenue / Employee (TTM)$862,100
Tangible BV / Share (Quarterly)$0.18
P/S Ratio (Annual)1.60x
Asset Turnover (Annual)0.97x
52-Week High$23.29
Operating Margin (5Y Avg)-33.78%
EPS Excl Extra (Annual)$-0.96
CapEx CAGR (5Y)16.50%
Tangible BV CAGR (5Y)-35.23%
26-Week Price Return-60.48%
Quick Ratio (Annual)1.22x
13-Week Price Return-44.68%
Total Debt / Equity (Annual)15.71x
Current Ratio (Quarterly)1.90x
Enterprise Value$1.65B
Revenue / Share Growth (5Y)18.68%
Asset Turnover (TTM)0.99x
Book Value / Share Growth (5Y)-26.19%
Revenue / Employee (Annual)$837,000
Inventory Turnover (Annual)1.35x
Pretax Margin (Annual)-18.77%
Cash / Share (Annual)$1.07
3-Month Return Std Dev88.47%
Gross Margin (5Y Avg)66.92%
Net Income / Employee (TTM)$-137,300
ROE (Last FY)-397.90%
Net Interest Coverage (Annual)-0.88x
EPS Basic Excl Extra (Annual)$-0.96
P/FCF (TTM)99.63x
Receivables Turnover (TTM)7.66x
Total Debt / Equity (Quarterly)31.41x
EPS Incl Extra (TTM)$-0.83
Receivables Turnover (Annual)7.86x
ROI (TTM)-20.98%
P/S Ratio (TTM)1.55x
Pretax Margin (5Y Avg)-37.33%
Revenue / Share (Annual)$5.09
Tangible BV / Share (Annual)$0.18
Forward P/E18.18x
Price vs S&P 500 (52W)-66.01%
Year-to-Date Return-63.17%
5-Day Price Return-6.29%
EPS Normalized (Annual)$-0.96
ROA (5Y Avg)-23.32%
Net Profit Margin (Annual)-18.76%
Month-to-Date Return-20.59%
Cash Flow / Share (TTM)$-1.06
EBITD / Share (Annual)$-0.56
Operating Margin (Annual)-13.05%
LT Debt / Equity (Annual)13.92x
P/CF (TTM)23.65x
ROI (5Y Avg)-31.16%
LT Debt / Equity (Quarterly)27.82x
EPS Basic Excl Extra (TTM)$-0.83
P/TBV (Quarterly)63.76x
P/B Ratio (Annual)86.75x
Inventory Turnover (TTM)1.32x
Pretax Margin (TTM)-15.92%
Book Value / Share (Annual)$0.24
Price vs S&P 500 (13W)-54.43%
Beta0.88x
P/FCF (Annual)270.41x
Revenue / Share (TTM)$5.11
ROE (TTM)-366.63%
52-Week Low$6.82
vGradeD
gGradeB
mGradeF
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.00est. -0.02
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.11
4.11
4.11
4.11
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ATECAlphatec Holdings, Inc. | D | B | F | $7.48 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Alphatec Holdings is a medical technology company that develops spine surgery solutions for treating degenerative disc disease, spinal trauma, and congenital deformities. The company offers a portfolio of implants and surgical instruments across multiple fusion approaches—including anterior cervical, lateral interbody, and posterior lumbar procedures—designed to decompress nerves, stabilize the spine, and restore proper alignment. Its diverse product platform addresses a large and growing market for spinal surgery treatments.